Differential effect of tumor necrosis factor on proliferation of primary human keratinocytes and cell lines containing human papillomavirus types 16 and 18
✍ Scribed by Luisa Lina Villa; Katia Brito Lins Vieira; Xu-Fang Pei; Richard Schlegel
- Publisher
- John Wiley and Sons
- Year
- 1992
- Tongue
- English
- Weight
- 582 KB
- Volume
- 6
- Category
- Article
- ISSN
- 0899-1987
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Keratinocytes immortalized by human papillomaviruses (HPV) 16 and 18 are partially resistant to the inhibition of proliferation exerted by transforming growth factor‐β (TGF‐β). To determine if this finding reflects a generalized resistance to inhibitory cytokines, we studied the effect of tumor necrosis factor‐α (TNF‐α) on subconfluent cultures of both normal and HPV‐immortalized human foreskin keratinocytes. Whereas primary and HPV‐16‐immortalized keratinocytes were sensitive to TNF‐α, HPV‐18‐immortalized keratinocytes (and those immortalized by simian virus 40) were resistant to the inhibitory effects of this cytokine. The ability of HPV‐18 to induce a more resistant phenotype correlated with its more potent in vitro transforming activity and its apparent association with more aggressive tumors. Interestingly, the state of TNF‐induced growth inhibition in normal or HPV‐16—immortalized keratinocytes was not accompanied by a reduction in the expression of c‐myc RNA or protein. This contrasts sharply with the ability of TGF‐β to inhibit c‐myc RNA expression in normal cells. Evidently, the resistance of HPV‐immortalized keratinocytes to TNF‐β and TGF‐β proceeds along different regulatory pathways. © 1992 Wiley‐Liss, Inc.
📜 SIMILAR VOLUMES
## Abstract Interferon‐γ (IFN‐γ) is a product of activated T‐lymphocytes, and tumor necrosis factor‐α (TNF‐α) is a product of both lymphocytes and macrophages. These cell types are often present at sites of tissue damage secondary to chronic infection or autoimmune disease. The purpose of this stud
Regional administration of high doses of tumor necrosis factor (TNF), interferon gamma (IFNgamma) and melphalan to patients with advanced cancers of the limbs, results in rapid and specific tumor necrosis, while the normal adjacent tissues remain unaffected. The tumor vasculature is selectively dest